Risk Factors for Invasive Cryptococcus Neoformans Diseases: a Case-control Study

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2015 Mar 10

PMID 25747471

Citations 56

Authors

Ying-Ying Lin

Stephanie Shiau

Chi-Tai Fang

Affiliations

Soon will be listed here.

Abstract

Background: Cryptococcus neoformans is a ubiquitous environmental fungus that can cause life-threatening meningitis and fungemia, often in the presence of acquired immunodeficiency syndrome (AIDS), liver cirrhosis, diabetes mellitus, or other medical conditions. To distinguish risk factors from comorbidities, we performed a hospital-based, density-sampled, matched case-control study.

Methods: All new-onset cryptococcal meningitis cases and cryptococcemia cases at a university hospital in Taiwan from 2002-2010 were retrospectively identified from the computerized inpatient registry and were included in this study. Controls were selected from those hospitalized patients not experiencing cryptococcal meningitis or cryptococcemia. Controls and cases were matched by admission date, age, and gender. Conditional logistic regression was used to analyze the risk factors.

Results: A total of 101 patients with cryptococcal meningitis (266 controls) and 47 patients with cryptococcemia (188 controls), of whom 32 patients had both cryptococcal meningitis and cryptococcemia, were included in this study. Multivariate regression analysis showed that AIDS (adjusted odds ratio [aOR] = 181.4; p < 0.001), decompensated liver cirrhosis (aOR = 8.5; p = 0.008), and cell-mediated immunity (CMI)-suppressive regimens without calcineurin inhibitors (CAs) (aOR = 15.9; p < 0.001) were independent risk factors for cryptococcal meningitis. Moreover, AIDS (aOR = 216.3, p < 0.001), decompensated liver cirrhosis (aOR = 23.8; p < 0.001), CMI-suppressive regimens without CAs (aOR = 7.3; p = 0.034), and autoimmune diseases (aOR = 9.3; p = 0.038) were independent risk factors for developing cryptococcemia. On the other hand, diabetes mellitus and other medical conditions were not found to be risk factors for cryptococcal meningitis or cryptococcemia.

Conclusions: The findings confirm AIDS, decompensated liver cirrhosis, CMI-suppressive regimens without CAs, and autoimmune diseases are risk factors for invasive C. neoformans diseases.

Citing Articles

Speckled-egg staining appearance of cryptococcal osteomyelitis in an immunocompetent patient.

Stack M, Lavik J, Schneider J, Cross B IDCases. 2025; 39:e02171.

PMID: 39989946 PMC: 11847515. DOI: 10.1016/j.idcr.2025.e02171.

Invasive fungal infections in patients with liver disease: immunological and clinical considerations for the intensive care unit.

Epelbaum O, de Moraes A, Olson J, Lionakis M Intensive Care Med. 2025; 51(2):364-377.

PMID: 39961846 PMC: 11903580. DOI: 10.1007/s00134-025-07797-1.

Comparison of mNGS with conventional methods for diagnosis of cryptococcal meningitis: a retrospective study.

Jiang Z, Hong J, Lin B, Zhang W, Fan Q, Yang B Sci Rep. 2025; 15(1):3656.

PMID: 39880818 PMC: 11779966. DOI: 10.1038/s41598-025-86481-2.

Elements of dissemination in cryptococcosis.

Bednarek J, Brown J mBio. 2024; 15(12):e0215523.

PMID: 39470312 PMC: 11633103. DOI: 10.1128/mbio.02155-23.

Fungal infections in liver cirrhosis.

Iqbal H, Mehmood B, Jones K, Sohal A, Roytman M Transl Gastroenterol Hepatol. 2024; 9:49.

PMID: 39091651 PMC: 11292070. DOI: 10.21037/tgh-24-6.

References

Odom A, Muir S, Lim E, Toffaletti D, Perfect J, Heitman J . Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J. 1997; 16(10):2576-89. PMC: 1169869. DOI: 10.1093/emboj/16.10.2576. View

Tseng H, Liu C, Ho M, Lu P, Lo H, Lin Y . Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997-2010. PLoS One. 2013; 8(4):e61921. PMC: 3629109. DOI: 10.1371/journal.pone.0061921. View

Eng R, Bishburg E, Smith S, Kapila R . Cryptococcal infections in patients with acquired immune deficiency syndrome. Am J Med. 1986; 81(1):19-23. DOI: 10.1016/0002-9343(86)90176-2. View

Jiang Y, Chang C, Tai T, Chen J, Chuang L . Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000-2009 Nationwide Health Insurance database. J Formos Med Assoc. 2012; 111(11):599-604. DOI: 10.1016/j.jfma.2012.09.014. View

Zoller W, Kellner H, Goebel F, Schmiedtke K, Holecek B, Staib F . [Cryptococcus neoformans meningoencephalitis and multiple infections in AIDS]. Klin Wochenschr. 1989; 67(11):598-604. DOI: 10.1007/BF01721688. View

Akalin H, Laleli Y, Telatar H . Serum bactericidal and opsonic activities in patients with non-alcoholic cirrhosis. Q J Med. 1985; 56(220):431-7. View

Mitchell T, Perfect J . Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev. 1995; 8(4):515-48. PMC: 172874. DOI: 10.1128/CMR.8.4.515. View

Chuang Y, Ho Y, Chang H, Yu C, Yang P, Hsueh P . Disseminated cryptococcosis in HIV-uninfected patients. Eur J Clin Microbiol Infect Dis. 2007; 27(4):307-10. DOI: 10.1007/s10096-007-0430-1. View

. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2005; 29 Suppl 1:S43-8. View

10.

Chuck S, Sande M . Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med. 1989; 321(12):794-9. DOI: 10.1056/NEJM198909213211205. View

11.

Kovacs J, Kovacs A, Polis M, Wright W, Gill V, Tuazon C . Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med. 1985; 103(4):533-8. DOI: 10.7326/0003-4819-103-4-533. View

12.

Pfaller M, Diekema D . Epidemiology of invasive mycoses in North America. Crit Rev Microbiol. 2010; 36(1):1-53. DOI: 10.3109/10408410903241444. View

13.

Cauley L, Murphy J . Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection. Infect Immun. 1979; 23(3):644-51. PMC: 414213. DOI: 10.1128/iai.23.3.644-651.1979. View

14.

Singh N, Alexander B, Lortholary O, Dromer F, Gupta K, John G . Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis. 2007; 195(5):756-64. PMC: 2746485. DOI: 10.1086/511438. View

15.

Bermas B, Petri M, Goldman D, Mittleman B, Miller M, Stocks N . T helper cell dysfunction in systemic lupus erythematosus (SLE): relation to disease activity. J Clin Immunol. 1994; 14(3):169-77. DOI: 10.1007/BF01533366. View

16.

Salkowski C, Balish E . Cutaneous cryptococcosis in athymic and beige-athymic mice. Infect Immun. 1991; 59(5):1785-9. PMC: 257916. DOI: 10.1128/iai.59.5.1785-1789.1991. View

17.

Sun H, Hung C, Chang S . Management of cryptococcal meningitis with extremely high intracranial pressure in HIV-infected patients. Clin Infect Dis. 2004; 38(12):1790-2. DOI: 10.1086/421272. View

18.

DeMeo A, Andersen B . Defective chemotaxis associated with a serum inhibitor in cirrhotic patients. N Engl J Med. 1972; 286(14):735-40. DOI: 10.1056/NEJM197204062861401. View

19.

Nishimura K, Miyaji M . Histopathological studies on experimental cryptococcosis in nude mice. Mycopathologia. 1979; 68(3):145-53. DOI: 10.1007/BF00578522. View

20.

. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992; 41(RR-17):1-19. View